Streamlining the Digital Health Revolution
Stephanie has over 20 years’ experience, from executive roles at Oracle and IBM, to leading her startup through a public company acquisition. She thrives building aligned, high-performing teams, compelling storytelling platforms, and meaningful market-defining products.Stephanie Trunzo is senior vice president and general manager for Oracle Health. Her diversely skilled team, Oracle Health Marketing and Consumer Experience, is responsible for product and engineering, marketing, and business value and innovation. While Stephanie is a tech geek across cloud, AI, and emerging tech, she is also a storyteller with a commitment to usability and design thinking. This is reflected in the mission of Oracle Health: to create a human-centric healthcare experience powered by unified global data. To deliver value to consumers, Stephanie is reimagining healthcare by putting humans at the center of Oracle Health systems and applications. Stephanie helped lead the launch of Oracle Health and was part of the core acquisition team working closely with Cerner, now part of Oracle Health. Previously, Stephanie applied her digital and experience disciplines to create and deploy Oracle’s global, value-based approach for multicloud, hybrid customer strategies. Stephanie joined Oracle from IBM where she was the global head of IBM Cloud Garage, a network of more than one dozen innovation hubs purpose-built to meld industry practices, startup culture, and IBM's expertise. Prior to that, she founded and led her digital transformation startup through a public acquisition to Globant. Stephanie was affectionately dubbed “the prototype” for the chief digital officer role by the CDO Club. She is an active advisor, giving back to nonprofits and early startups including TechGirlz, WomenNC, and InsureLife. Her writing can be found in publications such as Fast Company, Forbes, and HuffPost.
Stephanie has over 20 years’ experience, from executive roles at Oracle and IBM, to leading her startup through a public company acquisition. She thrives building aligned, high-performing teams, compelling storytelling platforms, and meaningful market-defining products.Stephanie Trunzo is senior vice president and general manager for Oracle Health. Her diversely skilled team, Oracle Health Marketing and Consumer Experience, is responsible for product and engineering, marketing, and business value and innovation. While Stephanie is a tech geek across cloud, AI, and emerging tech, she is also a storyteller with a commitment to usability and design thinking. This is reflected in the mission of Oracle Health: to create a human-centric healthcare experience powered by unified global data. To deliver value to consumers, Stephanie is reimagining healthcare by putting humans at the center of Oracle Health systems and applications. Stephanie helped lead the launch of Oracle Health and was part of the core acquisition team working closely with Cerner, now part of Oracle Health. Previously, Stephanie applied her digital and experience disciplines to create and deploy Oracle’s global, value-based approach for multicloud, hybrid customer strategies. Stephanie joined Oracle from IBM where she was the global head of IBM Cloud Garage, a network of more than one dozen innovation hubs purpose-built to meld industry practices, startup culture, and IBM's expertise. Prior to that, she founded and led her digital transformation startup through a public acquisition to Globant. Stephanie was affectionately dubbed “the prototype” for the chief digital officer role by the CDO Club. She is an active advisor, giving back to nonprofits and early startups including TechGirlz, WomenNC, and InsureLife. Her writing can be found in publications such as Fast Company, Forbes, and HuffPost.
David Hodgson is co-founder and CEO of Project Ronin, an oncology intelligence platform designed to fundamentally redefine cancer care, with oncologists and their patients at the center. Under his leadership, Project Ronin has partnered with the world’s top oncologists and technologists to develop deep learning and contextualized patient analytics at the point of care.Prior to founding Project Ronin, he has over 20 years’ experience in senior executive roles at both major life science companies (Pfizer, Roche) and fast-growing young healthcare companies (One Medical Group, Tethys, Oxeon Partners). David was the former CTO and early strategic partner during the founding and initial product launch for disruptive health startups including: Bright Health, Neurotrack, and Genome Medical, Syapse, Empiric Health.David is recognized as a top innovator in healthcare technology – with broad expertise from market strategy through to product launch, successful incorporation and high company growth stages. Notably he led the most comprehensive translational discovery systems at Pfizer; the integrated clinical research platform at Roche; one of the earliest telehealth solutions at WellnessFX; and the end-to-end clinical decision support system at One Medical Group.David has authored market growth strategies and product strategy for numerous prominent healthcare organizations including Premera Blue Cross, Dignity Health, Intermountain Health and breastcancer.org as well as up-and-coming young companies including Syapse, Bright Health, Genome Medical, Neurotrack and more.David advises a number of startups and non-profit foundations and is published across various subjects from software design to therapeutic discovery strategy.
David Hodgson is co-founder and CEO of Project Ronin, an oncology intelligence platform designed to fundamentally redefine cancer care, with oncologists and their patients at the center. Under his leadership, Project Ronin has partnered with the world’s top oncologists and technologists to develop deep learning and contextualized patient analytics at the point of care.Prior to founding Project Ronin, he has over 20 years’ experience in senior executive roles at both major life science companies (Pfizer, Roche) and fast-growing young healthcare companies (One Medical Group, Tethys, Oxeon Partners). David was the former CTO and early strategic partner during the founding and initial product launch for disruptive health startups including: Bright Health, Neurotrack, and Genome Medical, Syapse, Empiric Health.David is recognized as a top innovator in healthcare technology – with broad expertise from market strategy through to product launch, successful incorporation and high company growth stages. Notably he led the most comprehensive translational discovery systems at Pfizer; the integrated clinical research platform at Roche; one of the earliest telehealth solutions at WellnessFX; and the end-to-end clinical decision support system at One Medical Group.David has authored market growth strategies and product strategy for numerous prominent healthcare organizations including Premera Blue Cross, Dignity Health, Intermountain Health and breastcancer.org as well as up-and-coming young companies including Syapse, Bright Health, Genome Medical, Neurotrack and more.David advises a number of startups and non-profit foundations and is published across various subjects from software design to therapeutic discovery strategy.